Biogen Inc. buy Cantor Fitzgerald
Start price
20.02.24
/
50%
€200.60
Target price
20.02.25
€287.58
Performance (%)
-35.17%
End price
21.02.25
€130.05
Summary
This prediction ended on 21.02.25 with a price of €130.05. The BUY prediction by Cantor_Fitzgerald for Biogen Inc. performed very badly with a performance of -35.17%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -7.266% | -7.266% | 27.107% |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $311.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten